National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Blood Stem Cell Transplants
< Back to Main
In English     En español
    Posted: 09/01/2006    Reviewed: 09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 24  :  Cord Blood as a Source of Stem Cells <  >  

The human body's most primitive stem cells form in the fetal yolk sac and move to the fetal liver before entering the baby's bone marrow during the third trimester of pregnancy. When a baby is born, the placenta and umbilical cord still contain a rich supply of immature blood stem cells in the very process of migrating. These stem cells are capable of rebuilding all three types of blood cells in the body (red blood cells, immune cells, and platelets). First used in 1989 to help children with leukemia, cord-blood transplants have since proven themselves effective for adults too.

Cord Blood as a Source of Stem Cells

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov